Your session is about to expire
← Back to Search
Bone Modifying Agents for Breast and Prostate Cancer
Study Summary
This trial will compare continuing or further reducing bone metastases treatment after two years in patients with breast or prostate cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 18 years old or older.I have been on bone-modifying agents for over 2 years for bone metastases.I have bone metastases from prostate or breast cancer and am receiving bone-modifying agents.I have or had bone disease in my jaw.I am scheduled for bone surgery or radiotherapy within a month after joining the study.I have been on bone-modifying agents for over 2 years for bone metastases.The following text is about someone who is able to provide verbal consentI have bone metastases from prostate or breast cancer and am on bone-modifying agents.I am 18 years old or older.
- Group 1: Standard BMA frequency
- Group 2: De-escalate BMA to once every 24 weeks
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What use cases tend to involve Standard BMA frequency treatment?
"Standard BMA frequency is an approved treatment for malignant neoplasms, osteoporosis, and males with low bone mineral density."
Are there any remaining opportunities to enroll in this research endeavor?
"Affirmative. Clinicaltrials.gov's records show that this research project is presently recruiting participants, beginning from October 9th 2020 and last updated on April 19th 2022. This trial requires the enrolment of 240 people at a single medical centre."
Has research been conducted that has explored Standard BMA frequency previously?
"Presently, 76 clinical trials are actively examining the efficacy of Standard BMA frequency; 20 of which have progressed to Phase 3. Though many studies for this procedure originate from Douliu in Yunlin County, there remain 1147 sites where clinical investigations into its effects are ongoing."
How many participants have been recruited for this clinical research program?
"Affirmative. According to the information on clinicaltrials.gov, this study is actively looking for volunteers and was first posted in October of 2020. It has most recently been updated in April of 2022 with a goal of enrolling 240 people at one site."
Has the FDA authorized the use of Standard BMA frequency?
"There is ample evidence to suggest that this treatment, Standard BMA frequency, has been approved and thus earned a score of 3."
Share this study with friends
Copy Link
Messenger